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OBJECTIVES We described morphologic characteristics, particularly pulmonary anatomy, and determined
the prevalence of definitive end states and their determinants in children with pulmonary
atresia associated with ventricular septal defect (PAVSD).
BACKGROUND Pulmonary atresia associated with ventricular septal defect represents a broad morphologic
spectrum that greatly influences management and outcomes.
METHODS From 1975 to 2004, 220 children with PAVSD presented to our institution. Blinded
angiographic review (n  171) characterized bronchopulmonary segment arterial supply.
RESULTS A total of 185 patients underwent surgery, and repair was definitive in 75%. Initial operations
included systemic-pulmonary artery shunt in 57%, complete primary repair in 31%, or right
ventricular outflow tract reconstruction in 12%. Based on angiographic review, 118 patients
had simple PAVSD and 53 patients had PAVSD with major aortopulmonary collateral
arteries (MAPCAs). Overall survival from initial operation was 71% at 10 years. Risk factors
for death after initial operation included younger age at repair, earlier birth cohort, fewer
bronchopulmonary segments supplied by native pulmonary arteries, and initial placement of
a systemic-pulmonary artery shunt. Competing-risks analysis for initially palliated patients
predicted that after 10 years, 68% achieved complete repair (with associated factors including
later birth cohort and more bronchopulmonary segments supplied by native pulmonary
arteries), 22% died without repair, and 10% remained alive without repair. Reoperations after
complete repair occurred in 38 children (27%), with risk factors including older age at
palliation, MAPCAs, and more segments supplied by collaterals.
CONCLUSIONS Outcomes in children with PAVSD have improved over time, and are better in completely
repaired cases. Bronchopulmonary arterial supply is an important determinant of mortality,
achievement of definitive repair, and post-repair reoperation. (J Am Coll Cardiol 2006;47:
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.10.0681448–56) © 2006 by the American College of Cardiology Foundation
o
p
s
t
n
t
c
s
M
P
t
a
w
r
a
fhe complexity of bronchopulmonary anatomy complicates
anagement of patients with pulmonary atresia and ven-
ricular septal defect (PAVSD) (1–5). Early primary repair
as been applied in patients with “simple” PAVSD (well-
eveloped central pulmonary arteries supplied by a ductus
rteriosus), analogous to the treatment paradigm for tetral-
gy of Fallot (6). Several groups have similarly advocated
ingle-stage complete unifocalization in patients with major
ortopulmonary collateral arteries (MAPCAs) (7,8), but
mportant interim attrition and morbidity with this ap-
roach mandates further evaluation. Management of pa-
ients with PAVSD and MAPCAs has evolved at the
ospital for Sick Children from a multi-staged approach to
From the *Department of Pediatric Cardiology, Göteborg University, The Queen
ilvia Children’s Hospital, Göteborg, Sweden; and the †Division of Cardiovascular
urgery, Department of Surgery, ‡Division of Cardiology, Department of Pediatrics,
nd the §Division of Diagnostic Imaging, Department of Radiology, University of
oronto, The Hospital for Sick Children, Toronto, Ontario, Canada.p
Manuscript received June 1, 2005; revised manuscript received October 4, 2005,
ccepted October 10, 2005.ne emphasizing complete single-stage unifocalization in
atients with adequate central pulmonary arterial size.
We sought to describe morphologic characteristics, with
pecial attention to pulmonary anatomy, and to determine
he prevalence of definitive end states and their determi-
ants in children with PAVSD. We also sought to charac-
erize outcomes over time and to establish whether trends
ould be correlated with the predominant management
trategy operational in that era.
ETHODS
atients. After approval by the Research Ethics Board at
he Hospital for Sick Children, 220 children 18 years of
ge with unrepaired PAVSD referred from 1975 to 2004
ere identified by the cardiology database and their medical
ecords were reviewed (Table 1). Data were collected from
dmission, before any intervention, and at the last available
ollow-up. Patients or caregivers were contacted by tele-
hone in cases in which current follow-up data were
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April 4, 2006:1448–56 Pulmonary Atresia with VSDnavailable. Median follow-up time was 3.8 years (ranging
o 26 years) from first admission, and is 98% complete for
urvivors.
ulmonary arterial anatomy. Pulmonary arterial anatomy
as documented by single-observer blinded review of the
nitial (n 171) and follow-up (n 98) angiograms (Table 1).
chocardiographic data were used for determination of
ntracardiac anatomy in patients without cardiac catheter-
zation (n  49). Central pulmonary arteries were located
ngiographically by relation to main bronchi, or by the
eagull sign (9). Pulmonary arteries and the aorta were
easured in the same angiogram or cardiac cycle phase.
on-dichotomous unpredictable peripheral branching was
onsidered abnormal, as were dilated and tortuous pulmo-
ary arteries. Stenoses were graded as present or absent.
irect collaterals were defined as native vessels arising from
he aorta, and indirect collaterals were defined as originating
rom major aortic branches (10). Based on initial angio-
raphic findings, the supply to the 18 bronchopulmonary
egments was defined using the following definitions: 1)
solated segments had no connection to the central pulmo-
ary arteries; 2) dual supplied segments were supplied by
ative pulmonary arteries via the ductus arteriosus and
ollaterals; 3) unperfused segments had no arterial supply;
nd 4) abnormal segments were defined qualitatively as
hose with an abnormal peripheral branching pattern. Pa-
ients with fully characterized pulmonary arterial anatomy
n  171) were then classified into two groups based on
hether the majority of the bronchopulmonary segments
ere supplied by collaterals, the MAPCA group (n  53),
r by native pulmonary arteries through the ductus arterio-
us, the non-MAPCA group (n  118). In follow-up
ngiograms, hemodynamic measurements were recorded,
nd right ventricular dilation, right and left ventricular
unction, and pulmonary regurgitation were qualitatively
escribed (Table 2).
ata analysis. Data are presented as frequency, median
ith range, or mean  SD as appropriate, with the number
f missing values indicated. Percentages, hazard functions,
nd competing risk estimates are presented with confidence
imits equivalent to 1 standard error (68%). All data analyses
ere performed using SAS statistical software (version 9,
AS Institute, Cary, North Carolina). Categorical and
ontinuous non-timed event outcomes were evaluated with
ultivariable logistic and linear regression analyses. Mul-
iphase parametric modeling of the hazard function (11) and
ompeting risks methodology (12,13) were used to deter-
Abbreviations and Acronyms
MAPCA  major aortopulmonary collateral arteries
PAVSD  pulmonary atresia associated with ventricular
septal defect
RVOT  right ventricular outflow tractine rates of transition to mutually exclusive time-related wvents. Multiphase parametric modeling (14) is a totally
arametric (as opposed to the semi-parametric method
stablished by Cox [15]) method of analysis that accommo-
ates both the time-related freedom from an event and also
he time-varying nature of risk (phases of risk) for that
vent. Hazard function analysis that incorporates these
hases is ideal for understanding many postoperative events,
ncluding those in the present study, in which the early risk
f an event such as death (i.e., hazard) after surgery is
nitially high, rapidly declines to a more constant non-zero
azard, followed by a later increase in risk thereafter.
The graphic depiction of overall survival generated from
odeling the hazard function (which in this case has two
hases) contains solid lines, which are continuous point
stimates enclosed by 70% confidence limits. Model build-
ng begins by nonparametric (Kaplan-Meier) estimation,
able 1. Initial Patient Characteristics (n  220)
Variable Value Missing
emographic characteristics
Admission age (yrs) 0 (0–10.6) 0
Gender (female/male) 114:106 0
Noncardiac anomaly 73 (34%) 4
Chromosomal anomaly 50 (23%) 0
orphologic characteristics
Type of pulmonary atresia
Muscular 94 (52%) 38
Valvular 58 (32%) 38
Segment gap 30 (16%) 38
VSD type
Perimembranous 180 (85%) 7
Muscular 18 (8%) 7
Restrictive 4 (2%) 7
Multiple 11 (5%) 7
Right aortic arch 66 (30%) 3
Aberrant subclavian artery 30 (14%) 13
Patent ductus arteriosus 115 (63%) 37
Coronary artery abnormality* 31 (19%) 54
Left superior vena cava† 14 (7%) 6
Aortic valve stenosis 9 (4%) 6
Aortic valve regurgitation 15 (8%) 20
Mitral valve abnormality‡ 4 (2%) 6
ulmonary arterial anatomy
LPA absent 15 (7%) 1
RPA absent 19 (9%) 1
Absent main pulmonary artery segment 22 (11%) 15
Non-confluent pulmonary arteries 30 (14%) 1
LPA branch stenosis 66 (37%) 41
RPA branch stenosis 32 (18%) 45
LPA proximal (cm) 4.7  2.7 44
LPA distal (cm)§ 4.9  2.8 61
RPA proximal (cm) 5.1  2.9 43
RPA distal (cm)§ 5.2  3.0 64
McGoon ratio 1.2  0.5 87
Nakata index (mm2·m2) 157  119 78
alues are median (range), n (%), or mean  SD. *Includes LAD artery from RCA
n 5, accessory LAD in 7, single left coronary artery in 9, single RCA in 2, coronary
rtery to pulmonary artery fistula in 5, and coronary-cameral fistula in 1. †Includes left
uperior vena cava to coronary sinus in 13 and left superior vena cava to left atrium in 1.
Includes parachute mitral valve in 3 and mild dysplasia in 1. §Measured before first
ranch point.
LAD  left anterior descending; LPA  left pulmonary artery; RCA  right
oronary artery; RPA  right pulmonary artery; VSD  ventriculoseptal defect.hich reveals the shape of risk over the period of
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Pulmonary Atresia with VSD April 4, 2006:1448–56ollow-up (i.e., is there early attrition followed by a
radual increase, or is there only ongoing constant risk?)
azard models are then constructed using the log-
ikelihood method, and model fit is also examined graph-
cally by comparing the parametric estimates to the non-
arametric estimates (shown in the graph as superimposed
ircles with error bars).
Competing risks analysis is a method of time-related data
nalysis in which multiple, mutually exclusive events are
onsidered simultaneously. Competing risks analysis is in-
egrative in that it considers multiple outcomes in the
ontext of one another, and can therefore address the
uestion of how often an event may occur in the presence of
ther events for which a patient is at simultaneous risk. A
amiliar example of this phenomenon is the estimated
revalence of prosthetic valve replacement adjusted for the
able 2. Patient Characteristics at Follow-Up
Variable Value Missing
linical follow-up (n  216)
Interval from admission (yrs) 3.8 (0–26) 0
Saturation (%) 91.3  10.8 81
Below 25% for weight 59 (44%) 81
ngiographic characteristics (n  98)
Interval from admission
(yrs, median, range)
6.7 (0–18) 0
Pulmonary arterial anatomy
Number of residual collaterals 1  1 9
LPA main branch stenosis 41 (46%) 9
RPA main branch stenosis 33 (37%) 9
Multilevel stenoses* 17 (19%) 9
Bilateral PA stenosis 17 (19%) 9
LPA proximal (cm) 10.0  5.0 15
LPA distal (cm)† 9.7  4.3 16
RPA proximal (cm) 11.1  4.9 16
RPA distal (cm)† 10.6  4.6 15
McGoon ratio 1.8  0.6 26
Nakata index (mm2·m2) 250  144 22
 McGoon ratio‡ 0.6 (0.7–1.8) 44
 Nakata index‡ 102 (205–520) 33
Intracardiac anatomy
Reduced LV function 2 (2%) 17
Reduced RV function 19 (26%) 25
RV dilation 52 (75%) 28
Pulmonary regurgitation 59 (81%) 25
Hemodynamic measurements
PA systolic pressure (mm Hg) 36  17 33
RV pressure/systemic pressure (%) 55  20 34
Clinical status (n  126)
Asymptomatic without limitations 73 (58%)
Asymptomatic except palpitations 1 (1%)
Asymptomatic except chest pain 1 (1%)
Mild exercise intolerance/dyspnea 14 (11%)
Severe exercise intolerance 24 (19%)
Feeding difficulties/poor weight gain 3 (2%)
Learning disability/developmental delay 8 (6%)
Other 2 (2%)
alues are median (range), mean  SD, or n (%). *Includes those with main branch
nd lobar branch stenosis. †Measured before the first branch point. ‡Calculated as
value at follow-up  initial value).
LV  left ventricle; PA  pulmonary artery; RV  right ventricle; other
bbreviations as in Table 1.stimated prevalence of death occurring before replacement.
n
rhe present study considers that patients make a transition
rom an initial state (called event-free survival after pallia-
ion) to two other states (complete repair and death without
omplete repair) that are considered to be terminating. All
alliated patients in this example begin alive at time zero,
nd thereafter migrate (or transition) to the two specified
nd states at a rate determined by the underlying hazard
unction. Rates of transition, or rates of migration, from the
nitial state to one of the events (called an end state) are
ndividual, independent hazard functions. Incremental risk
actors associated with each state were identified by multi-
ariable regression analysis as previously described (16).
athematical transformations of continuous variables, such
s logarithms, polynomials, and square or inverse functions,
ere used to optimize calibration of the variable to the
isk of outcome events, and interactions among retained
ariables in the model were considered in all multivari-
ble analyses. Variable selection was guided by bootstrap
alidation (16).
ESULTS
nitial morphologic characteristics. Bronchopulmonary
natomy is characterized by a continuous morphologic
pectrum, but as confirmation of our definition, MAPCA
atients are polarized at either end of this spectrum (Fig. 1).
ompared with those in the non-MAPCA group (n 
18), the 53 MAPCA patients had a smaller McGoon ratio
1.0  0.4 vs. 1.4  0.5), fewer bronchopulmonary seg-
ents supplied by the true pulmonary arteries (5.0 0.6 vs.
6.0  0.3), and more segments with a dual supply (9.0 
igure 1. Bronchopulmonary arterial anatomy in pulmonary atresia asso-
iated with ventricular septal defect (PAVSD) is characterized by a
ontinuous morphologic spectrum, but our definition of major aortopul-
onary collateral arteries (MAPCA) patients is supported by the obvious
olarization of those in the non-MAPCA group (closed circles) and those
n the MAPCA group (open circles). There is a strong negative correlation
r2  0.8; p  0.001) between increasing number of bronchopulmonary
egments supplied by the native pulmonary arteries and decreasing number
f bronchopulmonary segments with abnormal supply. Abnormal supply
umber of dual supplied segments  number of unperfused segments 
umber of collateral supplied segments; PA pulmonary artery; RVOT
ight ventricular outflow tract.
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April 4, 2006:1448–56 Pulmonary Atresia with VSD.9 vs. 1.0 0.3) or that were unperfused (2.0 0.3 vs. 0.0
.1) (p  0.001 for all).
nitial surgical procedures. OVERALL. Of the initial 220
atients, operative intervention was undertaken at first
dmission in 187 at a median age of 18 days (range, 0 to
0.6 years), 2 of whom had exploration only without any
eparative procedure (Fig. 2). Systemic-pulmonary artery
hunts included modified Blalock-Taussig shunts and end-
o-side (“Mee”) shunts. Right ventricular outflow tract
RVOT) reconstruction included the following procedures:
urgical valvotomy with or without concomitant transannu-
ar patching, transannular patch placement, or interposition
f a conduit between the right ventricle and the pulmonary
rtery. Two patients late in the series had radiofrequency-
ssisted valvotomy and balloon dilation. Initial procedures
ere performed in 36 patients whose angiograms were
navailable for blinded angiographic review, including
ystemic-pulmonary artery shunt in 20, primary complete
epair in 14, and RVOT reconstruction in 2 patients.
ON-MAPCA PATIENTS (n  118). A flowchart of events in
atients according to diagnostic group is shown in (Fig. 3).
our patients without MAPCAs, but with other severe
on-cardiac anomalies, had no operative intervention. Pal-
igure 2. Overview of events in all patients admitted with a diagnosis of p
ight ventricular outflow tract.igure 3. Events in the 171 patients who underwent blinded angiographic review
ollateral arteries (n  53), and those without major aortopulmonary collateraliation was performed in 83 and primary complete repair,
efined as VSD closure and RVOT reconstruction, oc-
urred in 31 patients.
APCA PATIENTS (n  53). Eighteen patients with MAPCAs
ad no operative intervention. The MAPCA patients were
ore likely to have non-operative management (odds ratio
OR], 14.7; 95% confidence interval [CI], 4.6 to 46.2; p 
.001) Palliation was performed in 23 patients, including
VOT reconstruction in 13 and systemic-pulmonary artery
hunt in 10 patients. Procedures directed at MAPCAs con-
omitant with RVOT reconstruction included complete uni-
ocalization in 5 and partial unifocalization and ligation in 1
atient each. Systemic-pulmonary artery shunts occurred si-
ultaneously with partial unifocalization in 7 patients. Single-
tage complete repair, defined as VSD closure, RVOT recon-
truction, and single-stage complete unifocalization, occurred
n 12 patients.
volution of initial surgical management over time. Pri-
ary complete repair (n  57) was strongly associated with
ore recent era of operation for all patients regardless of
ulmonary arterial anatomy, with 67% (n  38) of initial
epairs occurring in era 3 (1995 to 2004), compared with
nly 32% (n  18) in era 2 (1985 to 1994), and only 2%
nary atresia associated with ventricular septal defect (PAVSD). RVOT ulmo. Patients were classified into two groups, those with major aortopulmonary
arteries (MAPCAs) (n  118).
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Pulmonary Atresia with VSD April 4, 2006:1448–56n  1) in era 1 (1975 to 1984) (p  0.0001) (Fig. 4). In the
APCA group, 83% (n  10) of complete primary repairs
ccurred era 3, compared with only 17% (n  2) in era 2,
nd none in era 1 (p  0.0001). Similarly, in the non-
APCA group, 97% (n  30) of initial repairs occurred in
ra 2 and 3, compared with 3% (n  1) in era 1 (p 
.0001).
nitial catheter interventions. Initial procedures occurred
n 23 patients before repair, including balloon dilatation of
ranch pulmonary arteries  stent placement in 12, collat-
ral coiling in 7, and pulmonary valve perforation in 4
atients.
verall mortality. Overall time-related survival from ini-
ial operation was 71% at 10 years (Fig. 5). Mortality rate
fter initial operation was highest during the first year after
peration and tapered thereafter. Incremental risk factors
or time-related death after operation were sought and are
isted in Table 3. Thirty deaths (25%) occurred in patients
ithout MAPCAs, and 21 occurred (40%) in the MAPCA
roup (p  0.06).
chievement of definitive repair. Complete repair oc-
urred in 139 patients at a median age of 2 years (range, 0
o 15 years). Primary repair without prior palliation occurred
n 57 patients. Staged repair was accomplished in 82
atients, 63 in the non-MAPCA group, 9 in the MAPCA
roup, and 10 in patients without angiographic review.
ompeting risks analysis for the 128 patients who under-
ent initial palliation predicted that at 10 years after
alliation, 68% had achieved complete repair, 22% had died
ithout complete repair, and 10% remained alive without
igure 4. Proportion of patients reaching definitive repair stratified by era.
he percentage of patients undergoing primary complete repair (open
ars) increased significantly with increasing era, reflecting an important
hange in the treatment paradigm for children with pulmonary atresia
ssociated with ventricular septal defect. The number of patients reaching
epair after prior palliation (solid bars) also predictably increased with
onger duration of follow-up. **p  0.0001.epair (Fig. 6). bFactors increasing transition rates to complete repair in
he 185 who underwent initial reparative operation included
ater birth cohort and more bronchopulmonary segments
upplied by the true pulmonary arteries (Table 3). De-
reased transition rates to complete repair and increased
re-repair attrition are evident in patients with MAPCAs,
s shown in Figure 7.
utcomes after complete repair. REOPERATIONS. A total
f 38 children underwent 47 reoperations after complete
ntracardiac repair (Table 4). For the 139 patients who
nderwent complete repair, competing risks analysis pre-
icted that at 5 years after complete repair, 60% remained
live without subsequent operation, 28% had a second
peration, and 12% had died without reoperation. Incre-
ental risk factors for reoperation after complete intracar-
iac repair included being in the MAPCA group, older age
t initial palliation, and a greater number of collateral
egments (Table 3).
ATHETER-BASED REINTERVENTIONS. After complete in-
racardiac repair, 104 percutaneous interventions occurred in
6 patients at a median age of 1.1 years (range, 0 to 13 years)
rom repair, including balloon dilatation of branch pulmonary
rteries  stent placement in 75, balloon dilation  stent
lacement of existing RVOT conduit in 22, and collateral
oiling in 7 patients. Percutaneous interventions were more
revalent in the MAPCA group (25%) than in the non-
APCA group (17%), and at a decreased interval from
omplete repair (1 year vs. 4 years, p  0.003). Competing
isks analysis predicted that at 3 years after complete repair,
5% underwent catheter-based reintervention, 6% had died
ithout reintervention, and 59% remained alive without
eintervention. Risk factors for reintervention included use
f a homograft for RVOT reconstruction, older age at
omplete repair, and single-stage complete repair in
Years After Initial Operation
%
 F
re
ed
o
m
 f
ro
m
 D
ea
th
Overall Survival
1 year 83%
5 years 74%
10 years 71%
No at risk:
185            120 96 86 64 54
igure 5. Overall survival from initial operation in 185 children with
ulmonary atresia associated with ventricular septal defect. There were 47
eaths after initial operation. The hazard function for death after initial
peration was characterized by a steep early phase accounting for 14 events,
ollowed by a more gradual later phase accounting for 33 events. Solid lines
epresent parametric point estimates enclosed by 70% confidence limits;
ircles with error bars represent nonparametric estimates, and numbers at
ottom represent the number of patients followed up at that point.
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April 4, 2006:1448–56 Pulmonary Atresia with VSDAPCA patients (Table 3). A significant interaction ex-
sted, however, between complete repair in the MAPCA
roup and age at repair, showing that earlier single-stage repair
ncreased the risk of subsequent interventions (Fig. 8).
ollow-up data. Clinical follow-up from first admission
as obtained in 216 patients at a median interval of 3.8
ears. Mean oxygen saturation (%) at follow-up was higher
n patients who underwent primary complete repair (96 
) versus those who had staged palliation (90  12, p 
.001). Follow-up angiograms were obtained in 98 survivors
Table 3. Incremental Risk Factors for Time-R
Initial Operation
Variable
For death after initial operation in 185 patients
Younger age at repair (per yr)
Initial systemic-PA shunt
Earlier birth cohort (per yr)
Fewer segments supplied by native PAs
Fewer segments with a dual supply
For survival to complete repair after palliation in 128
Later birth cohort (per yr)†
More segments supplied by native PAs
For reoperation after complete repair in 139 patients
MAPCA group
More segments supplied by collaterals‡
Older age at palliation (per yr)
For reintervention after complete repair in 139 patie
RVOT reconstruction with homograft
Earlier age at repair (per yr)§
Single-stage complete repair of MAPCAs
Interaction term between age at repair and comple
of MAPCAs
*Percent (%) refers to the reliability determined by boo
transformation. ‡After inverse transformation. §After logari
MAPCA  major aortopulmonary collateral artery; PA
igure 6. Competing risks depiction of events after initial palliation in 128
hildren who underwent initial palliation, either right ventricular outflow
ract (RVOT) reconstruction (n  23) or initial systemic-pulmonary artery
hunt placement (n  105). Competing risks analysis predicted that at 10
ears after palliation, 68% had achieved complete repair, 22% had died
ithout complete repair, and 10% remained alive without complete repair.
olid lines represent parametric point estimates, dashed lines enclose 70%
onfidence limits, circles with error bars represent nonparametric esti-r
ates, numbers in parentheses indicate the estimated proportion of
atients in each state at 10 years from palliation.62%) at a median interval of 6 years from initial admission
Table 2). Mean right ventricular/systemic pressure (%) was
5  20. Asymptomatic clinical status was associated with
rimary complete repair (OR, 3.6; 95% CI, 1.2 to 10.9; p
.02), achievement of complete repair at any time (OR,
3.0; 95% CI, 3.7 to 47; p  0.001), and the absence of
APCAs (OR, 0.3; 95% CI, 0.1 to 0.8; p  0.01) on
ultivariable analysis after adjustment for follow-up duration
nd operation era. At 6 years after initial operation, patients
ho underwent systemic-pulmonary artery shunts had less
ulmonary arterial growth (median Nakata 74; range, 133
o 430) than those undergoing other initial operations after
orrection for initial anatomy (median Nakata 102; range,
05 to 520), p  0.08.
ISCUSSION
ortality. The 10-year survival in our series of 71% is
igher than in other historical series (3,17,18). Incremental
isk factors for death after initial operation in this study
ncluded earlier birth cohort, systemic-pulmonary artery
hunt placement, increasing number of lung segments
upplied by MAPCAs, and younger age at complete repair.
mproved survival for those undergoing operation in a later
ra is multifactorial.
The prevalence of primary complete repair increased
ramatically in the later eras, as did the proportion of
atients reaching definitive repair. Similarly, the use of
ystemic-pulmonary artery shunts as the first stage decreased
ith later birth cohort in favor of RVOT reconstruction.
atients undergoing systemic-pulmonary artery shunts had
ncreased mortality independent of other factors, potentially
d Transition to End States After
Parameter Estimate
( SE) p
Reliability*
(%)
0.60  0.13 0.001 87
1.20  0.38 0.001 59
0.09  0.03 0.001 70
0.22  0.05 0.001 90
0.15  0.05 0.004 62
nts
0.004  0.005 0.001 85
0.09  0.03 0.003 78
2.7  0.97 0.005 55
0.21  0.98 0.03 60
0.22  0.12 0.07 72
1.40  0.73 0.06 70
0.23  0.06 0.001 79
4.46  0.89 0.001 63
air 3.85  1.46 0.008 —
validation (variable resampling) method. †After square
transformation.
onary artery; RVOT  right ventricular outflow track.elate
patie
nts
te rep
tstrapelated to decreased pulmonary parenchymal recruitment
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Pulmonary Atresia with VSD April 4, 2006:1448–56ith this technique (5,19,20). Decreased pulmonary arterial
rowth rate, measured by  Nakata index, in patients
ith shunts supports this contention. An earlier report by
reedom et al. (10) from our institution describing our
nitial experience with RVOT reconstruction showed no
onclusive benefit with respect to symmetric pulmonary
rterial growth, but included only 15 patients, only 5 of
hom had angiographic follow-up. The potential disadvan-
age of systemic-pulmonary artery shunts has been sug-
ested by the results from other series (5,19,20). Other
actors not evaluated in this study likely also contributed to
mproved results over time.
Variables relating to the morphology of the pulmonary
rterial circulation are well-known risk factors for death
fter repair, but their influence on other important
utcomes, including the achievement of complete repair,
eoperations, percutaneous reintervention, and long-term
linical status, has not been previously described (7,21–
igure 7. Competing risks diagrams depicting the estimated prevalence
chievement of complete repair, death without repair, and remaining al
higher prevalence of death are seen in a patient with only three bron
umber of major aortopulmonary collateral arteries (MAPCAs). (B) Pat
rteries via the ductus arteriosus, and therefore no MAPCAs, have inc4). We have fully characterized the bronchopulmonary
M
Rnatomy in the largest series of patients with PAVSD,
nd have shown that increased collateral supply adversely
mpacts end-state achievement independent of choice of
nitial management. This risk factor is likely a surrogate
or elevated pulmonary arterial or vascular resistance,
hich is inversely related to the number of pulmonary
rterial segments connected to an ipsilateral central
ulmonary artery (25). The importance of evaluating
able 4. Reoperations After Complete Intracardiac Repair
Operation n
onduit replacement 33
ulmonary valve insertion 6
ranch pulmonary arterioplasty 2
nifocalization 2
acemaker insertion 2
esection of RVOT aneurysm 1
igation of MAPCAs 1
ree mutually exclusive end states in 187 patients after initial operation:
ithout repair. (A) Decreased rates of transition to complete repair and
lmonary segments supplied by the true pulmonary arteries and a large
with all 18 bronchopulmonary segments supplied by the true pulmonary
d transition rates to complete repair and lower pre-repair attrition.of th
ive w
chopuAPCA  major aortopulmonary collateral artery; n  number of procedures;
VOT  right ventricular outflow tract.
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April 4, 2006:1448–56 Pulmonary Atresia with VSDulmonary arterial supply not only before initial treat-
ent but also throughout the patient’s clinical course is
ighlighted by the profound influence of bronchopulmo-
ary arterial anatomy on outcomes (22).
We were surprised that given the known advantages of
arly surgical intervention and the improved long-term
linical status in repaired cases, earlier age at repair was a
isk factor for death after operation. One potential explana-
ion is that median age at repair in our series is lower than
n many other reports despite the large preponderance of
taged patients (3,5,8,17,18,22,23,26). Thus, the finding of
arly repair as a risk factor may reflect the fact that the
esignation “early” is potentially arbitrary and depends on
ne’s perspective. More likely, however, is that commitment
o early definitive repair is a long-term investment requiring
ome initial cost. This is analogous to the evolution in
anagement favoring arterial switch operation over atrial
witch operation, in which the historically slightly higher
ortality of a new operation was mitigated by the potential
ong-term functional benefit (27). Patients who underwent
epair and survived had greater improvement in long-term
linical status, were less cyanosed, and had more favorable
ulmonary arterial characteristics at follow-up compared
ith those who remained palliated or did not undergo
urgery.
chievement of complete repair. Achievement of com-
lete repair occurred in 70% of patients in our study, which
as similar to the rates achieved in other reports
3,17,18,22). Later year of operation was strongly associated
ith definitive repair because of the increased prevalence of
igure 8. Risk-adjusted freedom from reintervention after repair for
arying age at complete repair stratified according to major aortopulmonary
ollateral artery (MAPCA) group. The multivariable equation from the
ompeting risk model was solved twice (for patients with MAPCAs and for
hose without), each time entering mean values for other predictors.
ecreased rates of catheter-based reintervention are illustrated for
APCA patients when single-stage repair is performed at a later age.
olid lines represent parametric determination of freedom from reinter-
ention for given age at repair; dashed lines enclose 70% confidence
ntervals.rimary repair and because enough time elapsed for previ-usly staged patients to reach this state. Patients who had
ndergone repair had acceptable mean right ventricular/left
entricular pressures at late follow-up and significant
rowth of the pulmonary arterial vascular bed.
Reoperation after definitive repair occurred frequently
nd was associated with increased number of MAPCAs and
ater age at initial palliation. Delayed palliation increases the
uration for which the collateral vessels are exposed to
ystemic arterial pressure and may predispose to the devel-
pment of pulmonary vascular obstructive disease in sup-
lied lung segments, especially in the absence of important
APCA stenoses (8). Encouraging, however, is that de-
pite the high incidence of post-repair reoperation, the
ajority of non-MAPCA survivors were asymptomatic and
linically well.
atheter-based reintervention. The MAPCA patients
ndergoing single-stage complete repair had an increased
isk of reintervention, and this effect was more pronounced
hen repair was performed at an earlier age. High reinter-
ention risk in this group may contribute to our finding that
ompletely repaired MAPCA patients had a worse clinical
tatus than completely repaired non-MAPCA patients.
dditionally, catheter-based intervention accounted for six
eaths in our series. Risk rates of reintervention in the
APCA group approximated those in the non-MAPCA
roup after 8 months of age, suggesting that delaying
ingle-stage repair outside of the neonatal period may afford
ome benefit. Although it can be argued that sequential
einterventions in patients with MAPCAs are mandated as
art of the treatment algorithm, and therefore may not
epresent adverse events per se, clear evidence supporting
his notion is currently lacking.
ONCLUSIONS
e have shown important improvement in outcomes over
ime that are associated with a shift in treatment paradigm
mphasizing primary repair for those with simple PAVSD
nd an individualized approach for those with MAPCAs
ailored to the adequacy of the pulmonary arterial bed. Our
esults confirm that RVOT reconstruction as the initial
rocedure is preferable to systemic-pulmonary artery shunt
lacement for patients in whom primary repair is not
easible, and that surgical decisions should be tailored to
ell-defined bronchopulmonary anatomy.
eprint requests and correspondence: Dr. Brian W. McCrindle,
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